Nonplacebo Controls to Determine the Magnitude of Ergogenic Interventions: A Systematic Review and Meta-analysis

Autor(es)

Marticorena, Felipe Miguel ^[1] ; Carvalho, Arthur ^[1] ; de Oliveira, Luana Farias ^[1] ; Dolan, Eimear ^[1] ; Gualano, Bruno ^{[2, 1]} ; Swinton, Paul ^[3] ; Saunders, Bryan ^{[4, 1]}

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Fac Med FMUSP, Rheumatol Div, Appl Physiol & Nutr Res Grp, Sch Phys Educ & Sport, Sao Paulo - Brazil

^[2] Univ Sao Paulo, Food Res Ctr FoRC, Sao Paulo - Brazil

^[3] Robert Gordon Univ, Sch Hlth Sci, Aberdeen - Scotland

^[4] Univ Sao Paulo, Fac Med FMUSP, Inst Orthopaed & Traumatol, Sao Paulo - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: MEDICINE AND SCIENCE IN SPORTS AND EXERCISE; v. 53, n. 8, p. 1766-1777, AUG 2021.
• Citações Web of Science: 4

Resumo

Introduction Placebos are used as a control treatment that is meant to be indistinguishable from the active intervention. However, where substantive placebo effects may occur, studies that do not include a nonplacebo control arm may underestimate the overall effect of the intervention (active plus placebo components). This study aimed to determine the relative magnitude of the placebo effect associated with nutritional supplements (caffeine and extracellular buffers) by meta-analyzing data from studies containing both placebo and nonplacebo control sessions. Methods Bayesian multilevel meta-analysis models were used to estimate pooled effects and express the placebo effect as a percentage of the overall intervention effect. Results Thirty-four studies were included, with the median pooled effect size (ES0.5) indicating a very small (ES0.5 = 0.09 (95% credible interval (CrI), 0.01-0.17)) improvement in the performance of placebo compared with control. There was no moderating effect of exercise type (capacity or performance), exercise duration, or training status. The comparison between active intervention and control indicated a small to medium effect (ES0.5 = 0.37 (95% CrI, 0.20-0.56)). Expressed in relative terms, the placebo effect was equivalent to 25% (75% CrI, 16%-35%) and 59% (75% CrI, 34%-94%) of the total intervention effect for buffers and caffeine. Conclusions These results demonstrate a very small but potentially important placebo effect with nutritional supplementation studies. A substantive proportion of supplement effects may be due to placebo effects, with the relative proportion influenced by the magnitude of the overall ergogenic effect. Where feasible, intervention studies should use nonplacebo control-arm comparators to identify the proportion of the effect estimated to come from placebo effects and avoid underestimating the overall benefits that the physiological plus psychobiological aspects associated with an intervention provide in the real world. (AU)

• Processo FAPESP: 19/26899-6 - A resposta óssea ao exercício: um programa de pesquisa translacional explorando aspectos clínicos e mecanísticos
• Beneficiário: Eimear Bernadette Dolan
• Modalidade de apoio: Bolsas no Brasil - Jovens Pesquisadores
• Processo FAPESP: 16/50438-0 - Suplementação nutricional e exercício para otimizar o desempenho: foco nas respostas individuais e um passo para a nutrição esportiva personalizada
• Beneficiário: Bryan Saunders
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores
• Processo FAPESP: 19/20614-0 - Influência do polimorfismo em MCT1 e MCT4 na performance e respostas sanguíneas frente a um teste de ciclismo de 1-km contrarrelógio em atletas recreacionais
• Beneficiário: Felipe Miguel Marticorena
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica